Atlas Trials

Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Clinical trial NCT02617069 · UNKNOWN

Trial details

NCT number
NCT02617069
Sponsor
Meshalkin Research Institute of Pathology of Circulation
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2015-09-01
Primary completion
2016-03-01
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.